Trump and Major Pharma Firms Agree to Lower Drug Prices
TL;DR
Several major pharmaceutical companies, including Merck, Bristol Myers Squibb, and Gilead, have agreed to lower drug prices in the U.S. through voluntary deals with President Trump, which include offering certain medications at discounted rates and listing drugs on a new direct-to-consumer platform, in exchange for a temporary exemption from tariffs and commitments to invest in U.S. manufacturing.
Topics:businesshealthcare#drug-prices#healthcare#medication-discounts#pharmaceutical-deals#trump-administration#us-healthcare
- Nine of the largest pharma companies ink deals with Trump to lower drug prices CNBC
- Trump Announces Pricing Deals With Nine Drugmakers The New York Times
- Trump announces ‘Most Favored Nation’ deals with nine drug companies, aiming to lower prices for US patients CNN
- Trump, nine pharmaceutical companies strike deal to cut prices Reuters
- Trump secures agreements with major drugmakers to lower Medicaid prescription costs for Americans Fox Business
Want the full story? Read the original reporting
Read on CNBC